Jason Kung, MD
Interventional Pain Medicine · Sacramento, CANPI 1013365154
Payments from drug & device makers
Across 537 payments — averaging $62.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$15K
- Medtronic$7K
- Abbott$2K
- Painteq LLC$1K
- Si-bone, Inc.$1K
- Spinal Simplicity, LLC$1K
- plus $5K from 27 others
Across 1 payment — averaging $16.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Saluda Medical Americas, Inc.$16
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 172 | $15,457 |
| Medtronic(2 entities) | 104 | $7,488 |
| Abbott | 63 | $1,927 |
| Painteq LLC | 15 | $1,341 |
| Si-bone, Inc. | 9 | $1,153 |
| Spinal Simplicity, LLC | 10 | $1,118 |
| Relievant Medsystems, Inc. | 33 | $1,033 |
| Electronic Waveform Lab, Inc. | 22 | $712 |
| Nevro Corp. | 17 | $701 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 30 | $506 |
| Saluda Medical Americas, Inc. | 4 | $304 |
| SPR Therapeutics, Inc | 3 | $194 |
| Biotronik NRO, Inc. | 3 | $171 |
| Stryker | 2 | $153 |
| Collegium Pharmaceutical, Inc. | 8 | $149 |
| Moximed, Inc | 1 | $144 |
| Scilex Pharmaceuticals Inc. | 7 | $126 |
| Vertex | 6 | $120 |
| Vertos Medical, Inc. | 1 | $107 |
| Biohaven Pharmaceuticals, Inc. | 5 | $99 |
| Amgen | 3 | $81 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $63 |
| Globus Medical | 2 | $54 |
| AbbVie | 3 | $53 |
| Nalu Medical, Inc. | 2 | $52 |
| Merck | 2 | $36 |
| Pacira Pharmaceuticals Incorporated | 1 | $26 |
| Novo Nordisk | 1 | $24 |
| Azurity Pharmaceuticals, Inc. | 1 | $20 |
| Eisai Inc. | 1 | $19 |
| Pfizer | 1 | $19 |
| IBSA Pharma Inc. | 1 | $17 |
| Redhill Biopharma Inc. | 1 | $15 |
How this compares
$33,481 in reported general payments places this provider in the 85th percentile of 188 interventional pain medicine providers in California.
See all interventional pain medicine providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional pain medicine in Sacramento
- Marc MaskowitzSacramento$13K
- Sheldon JordanSanta Monica$3.1M
- Ezekiel FinkBeverly Hills$2.3M
- Matthew DotyOroville$1.3M
- Tim LeierRancho Mirage$749K
- Pragya GuptaEscondido$647K
- Michael Verdolinla Mesa$563K
- Standiford HelmOrange$476K
- Patrick BuchananCamarillo$453K
- Roy BrownlowSan Diego$452K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.